Ling Feng

Title: Innovations of Inventor Ling Feng

Introduction

Ling Feng is a notable inventor based in Shanghai, China. He has made significant contributions to the pharmaceutical field, particularly in the development of novel compounds and their crystalline forms. With a total of four patents to his name, his work is recognized for its potential impact on medical treatments.

Latest Patents

Ling Feng's latest patents include innovative formulations that serve as inhibitors of phosphatidylinositol-3-kinase. One of his notable inventions provides crystalline forms, solvates, and pharmaceutical compositions of the compound (S)-4-amino-6-((1-(3-chloro-6-phenylimidazo[1,2-b]pyridazin-7-yl)ethyl)amino)pyrimidine-5-carbonitrile. Another significant patent involves the pharmaceutically acceptable salts of the compound (S)-7-(4-(1-(methylsulfonyl)piperidin-4-yl)phenyl)-N-(morpholin-2-ylmethyl)pyrido[3,4-b]pyrazin-5-amine, along with its crystalline forms and methods of preparation.

Career Highlights

Ling Feng is currently associated with Hutchison Medipharma Limited, where he continues to advance his research and development efforts. His work is characterized by a strong focus on pharmaceutical innovations that aim to improve therapeutic outcomes.

Collaborations

Ling Feng collaborates with esteemed colleagues, including Zhenping Wu and Wenji Li, who contribute to his research endeavors. Their combined expertise enhances the potential for groundbreaking discoveries in the pharmaceutical sector.

Conclusion

Ling Feng's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments and therapies.